{
    "Trade/Device Name(s)": [
        "Bionexia OptiCup"
    ],
    "Submitter Information": "MK Bio Inc",
    "510(k) Number": "K082977",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061005"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LDJ",
        "DIO",
        "LCM",
        "DNK",
        "DKZ",
        "DJR",
        "DJC",
        "DIS",
        "JXM",
        "LFG"
    ],
    "Summary Letter Date": "August 20, 2009",
    "Summary Letter Received Date": "July 21, 2009",
    "Submission Date": "October 2, 2008",
    "Regulation Number(s)": [
        "21CFR862.3870",
        "21CFR862.3250",
        "21CFR862.3100",
        "21CFR862.3640",
        "21CFR862.3610",
        "21CFR862.3620",
        "21CFR862.3150",
        "21CFR862.3170",
        "21CFR862.3910"
    ],
    "Regulation Name(s)": [
        "Marijuana test system",
        "Cocaine test system",
        "Phencyclidine Hydrochloride test system",
        "Morphine test system",
        "Methamphetamine test system",
        "Methadone test system",
        "Amphetamine test system",
        "Barbiturates test system",
        "Benzodiazepines test system",
        "Nortriptyline test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Marijuana",
        "Cocaine",
        "Phencyclidine",
        "Morphine",
        "Methamphetamine",
        "Methadone",
        "Amphetamine",
        "Barbiturates",
        "Benzodiazepines",
        "Nortriptyline"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Integrated cup"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay",
        "Lateral flow immunochromatography"
    ],
    "Methodologies": [
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for Bionexia OptiCup, a cup-format rapid immunoassay for simultaneous qualitative detection of multiple drugs of abuse in urine.",
    "Indications for Use Summary": "Qualitative and simultaneous detection of elevated levels of Marijuana, Cocaine, Phencyclidine, Morphine, Methamphetamine, Methadone, Amphetamine, Barbiturates, Benzodiazepines, and Nortriptyline in human urine for healthcare professional use only.",
    "fda_folder": "Toxicology"
}